ÌÇÐÄÆƽâ°æ

Sales forecast of leading pharmaceutical companies worldwide in 2030 (in billion U.S. dollars)

© ÌÇÐÄÆƽâ°æ 2026
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2026

Region

Worldwide

Survey time period

as of February 2026

Supplementary notes

The statistic includes only prescription drug revenue.

Citation formats

Sales forecast of major pharmaceutical companies worldwide 2030

Published by A. Minhas, Feb 10, 2026

In 2030, U.S.-based pharmaceutical company Eli Lilly is forecasted to generate around 107 billion U.S. dollars in sales revenue through prescription drugs, making it the world's leading drug manufacturer. Novo Nordisk followed with a forecasted revenue of about 93 billion U.S. dollars. 

Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Roche "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Roche

Company positioning & scale

5

Financial scale & structure

4

Portfolio, segments & geography

6

R&D, pipeline & innovation

6

Competitive landscape

5

Outlook & risk

4

Further Content: You might find this interesting as well

Topics

Global pharmaceutical industryPharmaceutical industry in the U.S.Top pharmaceutical drugsPfizerNovartis
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Register now
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

Professional Account

For teams of up to 99 users
Talk to sales for pricing
Contact us
  • Free + Premium Statistics
  • Reports
  • Market ÌÇÐÄÆƽâ°æ

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.